Ye Liu

Chief Executive Officer at OCUMENSION THERAPEUTICS

Net worth: 22 M $ as of 30/03/2024

53 year

Health Technology

Consumer Services

Profile

Ye Liu is currently the Chief Executive Officer & Executive Director at Ocumension Therapeutics and also serves as a Director at EyePoint Pharmaceuticals, Inc. Prior to his current roles, he served as Chairman & General Manager at Santen Pharmaceutical (China) Co. Ltd., General Manager at Eisai China, Inc., and Head-Sales at Sandoz (China) Pharmaceutical Co., Ltd.
Mr. Liu received his graduate degree from Dalhousie University in 2003 and his undergraduate degree from Zhongshan Hospital Fudan University in 1993.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
OCUMENSION THERAPEUTICS 4.37%	09/01/2024	30,384,480 ( 4.37% )	22 M $	30/03/2024

Ye Liu active positions

Companies	Position	Start
OCUMENSION THERAPEUTICS	Chief Executive Officer	31/07/2018
EYEPOINT PHARMACEUTICALS, INC.	Director/Board Member	31/12/2020

All active positions of Ye Liu

Former positions of Ye Liu

Companies	Position	End
Santen Pharmaceutical (China) Co. Ltd.	Chief Executive Officer	30/06/2018
Eisai China, Inc. Eisai China, Inc. Pharmaceuticals: MajorHealth Technology Eisai China, lnc. engages in the manufacture of pharmaceutical products. It offers medicines for digestive, endocrine, orthopedic, and cancer diseases. The company was founded on March 28, 1996 and is headquartered in Suzhou, China.	Chief Executive Officer	31/08/2014
Sandoz (China) Pharmaceutical Co., Ltd. Sandoz (China) Pharmaceutical Co., Ltd. Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz (China) Pharmaceutical Co., Ltd. is a global leader in generic pharmaceuticals and biosimilars. The private company is based in Shanghai, China. Sandoz is dedicated to helping patients increase drug accessibility and providing high-quality, affordable healthcare services to more patients worldwide. Founded in 2007, the Chinese company's purpose is to explore new methods of improving and extending people's lives.	Sales & Marketing	31/01/2009

See the detail of Ye Liu's experience

Training of Ye Liu

Dalhousie University	Graduate Degree
Zhongshan Hospital Fudan University	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ye Liu's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
EYEPOINT PHARMACEUTICALS, INC.	Health Technology
OCUMENSION THERAPEUTICS	Health Technology

Private companies	3
Santen Pharmaceutical (China) Co. Ltd.
Eisai China, Inc. Eisai China, Inc. Pharmaceuticals: MajorHealth Technology Eisai China, lnc. engages in the manufacture of pharmaceutical products. It offers medicines for digestive, endocrine, orthopedic, and cancer diseases. The company was founded on March 28, 1996 and is headquartered in Suzhou, China.	Health Technology
Sandoz (China) Pharmaceutical Co., Ltd. Sandoz (China) Pharmaceutical Co., Ltd. Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz (China) Pharmaceutical Co., Ltd. is a global leader in generic pharmaceuticals and biosimilars. The private company is based in Shanghai, China. Sandoz is dedicated to helping patients increase drug accessibility and providing high-quality, affordable healthcare services to more patients worldwide. Founded in 2007, the Chinese company's purpose is to explore new methods of improving and extending people's lives.	Health Technology

See company connections